Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
US |
|
C
|
Chongqing Brewery Co Ltd
SSE:600132
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BLAC.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BLAC Competitors Multiples
Bellevue Life Sciences Acquisition Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
58m USD | 0 | -122.2 | -26.7 | -26.7 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
241.2B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
98B ZAR | 5.6 | 10.5 | 14.2 | 14.3 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
65.5B USD | 0 | 36 989 | -17 320.4 | -17 320.4 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.7B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
39.4B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.7B EUR | 1 | 164.5 | 29.8 | 62.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
33B USD | 13.4 | -2 941.7 | -3 870.1 | -621.8 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
28.2B ZAR | 5.3 | 6.5 | 16.9 | 16.9 |